BDBM47100 US8937068, 156::US8937068, 175

SMILES CCNC(=O)Nc1ccc2ncc(nc2n1)-c1cc(Cl)c(O)c(OC)c1

InChI Key InChIKey=CJANMZPZNNYAPL-UHFFFAOYSA-N

Data  8 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 8 hits for monomerid = 47100   

TargetMitogen-activated protein kinase 1(Human)
Zentaris

US Patent
LigandPNGBDBM47100(US8937068, 156 | US8937068, 175)
Affinity DataIC50: 191nMAssay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/8/2015
Entry Details
Go to US Patent

LigandPNGBDBM47100(US8937068, 156 | US8937068, 175)
Affinity DataIC50: 458nMAssay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/8/2015
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 14(Human)
Zentaris

US Patent
LigandPNGBDBM47100(US8937068, 156 | US8937068, 175)
Affinity DataIC50: 1.00E+5nMAssay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/8/2015
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 8/9(Human)
Zentaris

US Patent
LigandPNGBDBM47100(US8937068, 156 | US8937068, 175)
Affinity DataIC50: 2.50E+3nMAssay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/8/2015
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 1(Human)
Zentaris

US Patent
LigandPNGBDBM47100(US8937068, 156 | US8937068, 175)
Affinity DataIC50: 138nMAssay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/8/2015
Entry Details
Go to US Patent

LigandPNGBDBM47100(US8937068, 156 | US8937068, 175)
Affinity DataIC50: 425nMAssay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/8/2015
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 14(Human)
Zentaris

US Patent
LigandPNGBDBM47100(US8937068, 156 | US8937068, 175)
Affinity DataIC50: 1.00E+5nMAssay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/8/2015
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 8/9(Human)
Zentaris

US Patent
LigandPNGBDBM47100(US8937068, 156 | US8937068, 175)
Affinity DataIC50: 2.10E+3nMAssay Description:The inhibitory effect of the compounds according to the invention was tested on various serine/threonine, tyrosine and lipid kinases in enzymatic ass...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/8/2015
Entry Details
Go to US Patent